PKE Stock Analysis: Park Aerospace | NYSE
Aerospace & Defense | NYSE, USA | Market Cap: 498m USD | 12M Return: 29.1% | US70014A1043 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 5.34M
EPS Trend: 76.3%
Qual. Beats: 0
Rev. Trend: 96.8%
Warnings
Tailwinds
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Park Aerospace Corp. (PKE) is a U.S.-based aerospace materials manufacturer that develops and produces advanced composite materials, including film adhesives and hot-melt resins, as well as lightning strike protection materials. These products are used to build primary and secondary composite structures for a broad range of aircraft platforms, such as jet engines, large and regional transport aircraft, military aircraft, unmanned aerial vehicles, business jets, general aviation, and rotary wing aircraft. The company also supplies specialty ablative materials for rocket motors and nozzles, engineered materials for radome applications, and offers composite parts, structures, assemblies, and low-volume tooling fabrication. Park Aerospace sells into North America, Asia, and Europe, was incorporated in 1954 (formerly known as Park Electrochemical Corp. until its 2019 rename), and is headquartered in Westbury, New York.
The aerospace composites sector is known for high barriers to entry due to long qualification and certification cycles required by regulators and OEMs, which tends to favor incumbent suppliers like PKE. As a tier-2/3 materials supplier focused on proprietary chemistries and formulations rather than large-scale airframe assembly, the company occupies a specialized niche upstream of major airframe and engine manufacturers.
- Boeing and Airbus production rate increases boost composite materials demand
- Defense spending and space launch activity expand specialty materials revenue
- Special dividends and share repurchases underscore disciplined capital allocation
| Net Income: 14.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 4.98 > 1.0 |
| NWC/Revenue: 165.9% < 20% (prev 124.5%; Δ 41.48% < -1%) |
| CFO/TA 0.08 > 3% & CFO 13.3m > Net Income 14.9m |
| Net Debt (-114.5m) to EBITDA (20.5m): -5.60 < 3 |
| Current Ratio: 22.75 > 1.5 & < 3 |
| Outstanding Shares: last quarter (21.2m) vs 12m ago 6.21% < -2% |
| Gross Margin: 32.68% > 18% (prev 29.50%; Δ 3.19% > 0.5%) |
| Asset Turnover: 55.31% > 50% (prev 54.21%; Δ 1.10% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.76 (Total Current Assets 139.9m - Total Current Liabilities 6.15m) / Total Assets 175.1m |
| B: -0.26 (Retained Earnings -45.5m / Total Assets 175.1m) |
| C: 0.13 (EBIT TTM 18.6m / Avg Total Assets 145.8m) |
| D: 13.18 (Book Value of Equity 162.7m / Total Liabilities 12.4m) |
| Altman-Z'' = 18.86 = AAA |
| DSRI: 0.92 (Receivables 14.8m/12.6m, Revenue 80.6m/63.1m) |
| GMI: 0.90 (GM 29.50% / 32.68%) |
| AQI: 0.79 (AQ_t 0.08 / AQ_t-1 0.10) |
| SGI: 1.28 (Revenue 80.6m / 63.1m) |
| TATA: 0.01 (NI 14.9m - CFO 13.3m) / TA 175.1m) |
| Beneish M = -3.11 (Cap -4..+1) = AA |
As of November 13, 2026, the stock is trading at USD 24.70 with a total of 157,561 shares traded. Over the past week, the price has changed by +9.20%, over one month by -9.26%, over three months by -34.85% and over the past year by +29.07%.
Current recommended Stop Loss: 23.20 (which is 6.1% or 1.3 ATR below the current price).
Park Aerospace has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy PKE.
- StrongBuy: 0
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 42.5 | 72.1% |
P/E Trailing = 34.8
P/E Forward = 17.094
P/S = 6.1812
P/B = 3.5389
P/EG = 1.4854
Revenue TTM = 80.6m USD
EBIT TTM = 18.6m USD
EBITDA TTM = 20.5m USD
Long Term Debt = 250k USD (estimated: total debt 296k - short term 46.0k)
Short Term Debt = 46.0k USD (from shortTermDebt, last quarter)
Debt = 296k USD (from shortLongTermDebtTotal, last quarter) (leases 296k already included)
Net Debt = -114.5m USD (calculated: Debt 296k - CCE 114.7m)
Enterprise Value = 383.9m USD (498.3m + Debt 296k - CCE 114.7m)
Interest Coverage Ratio = unknown (Ebit TTM 18.6m / Interest Expense TTM 0.0)
EV/FCF = 33.52x (Enterprise Value 383.9m / FCF TTM 11.5m)
FCF Yield = 2.98% (FCF TTM 11.5m / Enterprise Value 383.9m)
FCF Margin = 14.21% (FCF TTM 11.5m / Revenue TTM 80.6m)
Net Margin = 18.43% (Net Income TTM 14.9m / Revenue TTM 80.6m)
Gross Margin = 32.68% ((Revenue TTM 80.6m - Cost of Revenue TTM 54.3m) / Revenue TTM)
Gross Margin QoQ = 34.32% (prev 34.82%)
Tobins Q-Ratio = 2.19 (Enterprise Value 383.9m / Total Assets 175.1m)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 296k)
Taxrate = 23.45% (4.55m / 19.4m)
NOPAT = 14.2m (EBIT 18.6m * (1 - 23.45%))
Current Ratio = 22.75 (Total Current Assets 139.9m / Total Current Liabilities 6.15m)
Debt / Equity = 0.00 (Debt 296k / totalStockholderEquity, last quarter 162.7m)
Debt / EBITDA = -5.60 (Net Debt -114.5m / EBITDA 20.5m)
Debt / FCF = -9.99 (Net Debt -114.5m / FCF TTM 11.5m)
Total Stockholder Equity = 132.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 10.19% (Net Income 14.9m / Total Assets 175.1m)
RoE = 11.21% (Net Income TTM 14.9m / Total Stockholder Equity 132.6m)
RoCE = 13.98% (EBIT 18.6m / Capital Employed (Equity 132.6m + L.T.Debt 250k))
RoIC = 8.62% (NOPAT 14.2m / Invested Capital 164.9m)
WACC = 8.42% (E(498.3m)/V(498.6m) * Re(8.42%) + D(296k)/V(498.6m) * Rd(0.0%) * (1-Tc(0.23)))
Discount Rate = 8.42% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 61.44 | Cagr: 1.85%
[DCF] Terminal Value 77.76% ; FCFF base≈7.60m ; Y1≈8.71m ; Y5≈12.8m
[DCF] Fair Price = 13.85 (EV 190.8m - Net Debt -114.5m = Equity 305.2m / Shares 22.0m; r=8.42% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 76.30 | EPS CAGR: 24.31% | SUE: 0.74 | # QB: 0
Revenue Correlation: 96.82 | Revenue CAGR: 15.22% | SUE: N/A | # QB: 0
EPS current Quarter (2026-11-30): EPS=0.17 | Chg30d=+17.24% | Revisions=+40% | Analysts=2
EPS current Year (2027-02-28): EPS=0.73 | Chg30d=+8.96% | Revisions=+40% | GrowthEPS=+30.4% | GrowthRev=+0.0%
EPS next Year (2028-02-29): EPS=0.81 | Chg30d=+2.55% | Revisions=+40% | GrowthEPS=+10.3% | GrowthRev=+17.1%
[Analyst] Revisions Ratio: +67% (up=6, down=0)